Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

Low-cost biosensor identifies altered protein levels associated with psychiatric disorders

Brazilian researchers have developed a low-cost, portable biosensor that can quickly identify a protein whose altered levels are associated with psychiatric disorders, such as depression, schizophrenia, and bipolar disorder.

30 Oct 2025

Rethinking kindergarten reading screenings for better outcomes

In most states, schools are required to screen students as they enter kindergarten - a process that is meant to identify students who may need extra help learning to read. However, a new study by MIT researchers suggests that these screenings may not be working as intended in all schools.

29 Oct 2025

AI indelibly transforms solid tumor drug development

Artificial intelligence (AI) is fundamentally reshaping the landscape of solid tumor (ST) drug development.

29 Oct 2025

MAGIC: A powerful tool to understand the origin of cancer

The human body relies on precise genetic instructions to function, and cancer begins when these instructions get scrambled.

29 Oct 2025

Specialized type of cardiac fibroblasts can actively worsen heart failure

Heart failure (HF) is one of the leading causes of death and disability worldwide, affecting millions of people and placing an enormous burden on healthcare systems.

29 Oct 2025

AI-driven ECG improves detection of severe heart attacks

Using artificial intelligence (AI) to analyze electrocardiograms (ECG) improved detection of severe heart attacks, including those that presented with unconventional symptoms, or atypical ECG patterns, and reduced false positives, according to a study published in JACC: Cardiovascular Interventions and simultaneously presented at TCT 2025 in San Francisco.

29 Oct 2025

Novel AI ECG model outperforms standard triage for acute coronary occlusion

29 Oct 2025

Purdue researchers develop 30-second vaccine quality tool

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of new vaccines. A team of researchers at Purdue University and Merck & Co. Inc., known as Merck Sharp & Dohme Corp. outside of the U.S. and Canada, has now introduced a new analytical tool that could help pharmaceutical companies boost vaccine production with rapid monitoring and analysis.

29 Oct 2025

AI-powered LifeClock forecasts diseases years before symptoms appear

Researchers have developed LifeClock, an AI-driven biological clock trained on over 24 million electronic health records to estimate biological age across the human lifespan. The model accurately predicts disease risk years in advance, revealing distinct developmental and aging processes.

28 Oct 2025

Lessons from COVID-19 could help communities better prepare for the next pandemic

The COVID-19 pandemic has provided researchers with a wealth of information on contemporary successes and failures in combating an emerging pathogen.

28 Oct 2025

Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar disorder and pioneer novel neuromodulation-based treatment strategies.

28 Oct 2025

Using AI and citizen science for vector-borne disease surveillance

Researchers from the University of South Florida have used artificial intelligence and citizen science to identify what may be the first specimen of Anopheles stephensi - an invasive and deadly malaria-carrying mosquito - ever detected in Madagascar.

28 Oct 2025

CZI and NVIDIA collaborate to accelerate life science research through virtual cell models

Today, the Chan Zuckerberg Initiative (CZI) and NVIDIA announced an expanded collaboration to accelerate life science research by driving development and adoption of virtual cell models through tools, data, models, and benchmarks delivered through CZI's virtual cells platform (VCP).

28 Oct 2025

Circadian rhythm disruptions may increase the risk of cardiovascular disease

As modern lifestyles increasingly challenge the body's natural circadian rhythm, the American Heart Association is spotlighting the potential health consequences of regular disruptions to our body's internal clock with a new scientific statement published today in its flagship journal Circulation.

28 Oct 2025

New technology improves the efficiency of protein production in E. coli

Proteins sourced from microorganisms are attracting attention for their potential in biomanufacturing a variety of products, including pharmaceuticals, industrial enzymes, and diagnostic antibodies.

28 Oct 2025

Africa CDC’s vision for AI-driven primary health care and self-reliance

As African countries work to strengthen their health systems after years of donor dependence, the Africa Centres for Disease Control and Prevention (Africa CDC) is placing renewed emphasis on primary health care and digital innovation.

27 Oct 2025

Using machine learning to shed light on how well the triage systems work

A multinational collaboration at Eitri medical innovation center in Bergen, Norway, has used machine learning models to identify patient groups at risk of being mistreated.

27 Oct 2025

As sports betting explodes, states try to set limits to stop gambling addiction

It isn't easy to promote moderation and financial discipline from the bowels of a casino.

27 Oct 2025

New epimodulation approach improves outbreak forecasts

During an epidemic, some of the most critical questions for healthcare decision-makers are the hardest ones to answer: When will the epidemic peak, how many people will need treatment at once and how long will that peak level of demand for care last? Timely answers can help hospital administrators, community leaders and clinics decide how to deploy staff and other resources most effectively.

24 Oct 2025

Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment

A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment.

24 Oct 2025